BioSpace News Archive

Press Releases

Valitor Presents New Preclinical Data Demonstrating VLTR-559, an Anti-VEGF Drug Candidate for Wet AMD with a Twice-Yearly “Treat-and-Release” Regimen, Exhibits Favorable Safety Profile Similar to Short-Acting Anti-VEGFs

September 5, 2025
·
4 min read
Press Releases

Daxor’s Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care

September 5, 2025
·
5 min read
Press Releases

Ashvattha Therapeutics Announces Positive Topline 40-Week Phase 2 Results for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

September 5, 2025
·
5 min read
Press Releases

Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference

September 5, 2025
·
4 min read
Press Releases

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

September 5, 2025
·
1 min read
Press Releases

Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

September 5, 2025
·
6 min read
Press Releases

MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity

September 5, 2025
·
7 min read
Press Releases

Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference

September 5, 2025
·
5 min read
Press Releases

Cidara Therapeutics to Participate in September 2025 Investor Conferences

September 5, 2025
·
1 min read
Press Releases

Beacon Therapeutics Announces Positive Interim 9+ Month Results from DAWN Trial and 36-Month Phase 2 SKYLINE Trial Data for Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at EURETINA 2025

September 5, 2025
·
5 min read